Genome‐wide <scp>DNA</scp> methylation analysis identifies potent <scp>CpG</scp> signature for temzolomide response in <scp>non‐G‐CIMP</scp> glioblastomas with unmethylated <scp><i>MGMT</i></scp> promoter: <scp><i>MGMT</i></scp>‐dependent roles of <scp><i>GPR81</i></scp>
CNS neuroscience & therapeutics